Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel

Biomaterials

Volumn 33, Issue 32, 2012, Pages 8003-8016

  Chien, Yueh ^a,f   Liao, Yi Wen ^a   Liu, Dean Mo ^b   Lin, Heng Liang ^a   Chen, Shih Jen ^a,f   Chen, Hen Li ^a   Peng, Chi Hsien ^a,c   Liang, Chang Min ^d   Mou, Chung Yuan ^e   Chiou, Shih Hwa ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chitin chitosan; Cornea; Hydrogel; Stem cell; Wound healing

Indexed keywords

CELL SOURCES; CHITIN/CHITOSAN; CHITOSAN HYDROGEL; COMBINED TREATMENT; CORNEA; CORNEAL DAMAGE; CULTURE MEDIA; DELIVERY SYSTEMS; EPITHELIAL CELLS; EPITHELIAL THICKNESS; FEEDER CELLS; HUMAN CORNEAL; KERATOCYTES; NANO SCALE; PLURIPOTENT; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; WOUND HEALING;

CELL CULTURE; GENE EXPRESSION; REPAIR; STEM CELLS; SURGERY;

HYDROGELS;

ALPHA FETOPROTEIN; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TUBULIN; CARBOXYMETHYL HEXANOYL CHITOSAN; CHITOSAN DERIVATIVE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NANOCAPSULE; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN DPPA2; REACTIVE OXYGEN METABOLITE; REX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENGINEERING; CELL VIABILITY; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA SURGERY; CORNEA THICKNESS; DOWN REGULATION; GELATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; WOUND HEALING;

ANIMALS; CELLS, CULTURED; CHITOSAN; CORNEA; CORNEAL KERATOCYTES; HUMANS; HYDROGEL; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; RATS; WOUND HEALING;

EID: 84865556569     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.029     Document Type: Article

References (48)

1. Cotsarelis G., Cheng S.Z., Dong G., Sun T.T., Lavker R.M. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989, 57(2):201-209.
2. Davanger M., Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971, 229(5286):560-561.
3. Zhao X., Das A.V., Thoreson W.B., James J., Wattnem T.E., Rodriguez-Sierra J., et al. Adult corneal limbal epithelium: a model for studying neural potential of non-neural stem cells/progenitors. Dev Biol 2002, 250(2):317-331.
4. Grueterich M., Tseng S.C. Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol 2002, 120(6):783-790.
5. Arsenijevic Y., Taverney N., Kostic C., Tekaya M., Riva F., Zografos L., et al. Non-neural regions of the adult human eye: a potential source of neurons?. Invest Ophthalmol Vis Sci 2003, 44(2):799-807.
6. Tsai R.J., Li L.M., Chen J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000, 343(2):86-93.
7. Srinivasan R., Gupta A., Kaliaperumal S. Hypopyon iritis after primary fresh amniotic membrane transplantation. Cornea 2007, 26(10):1275-1276.
8. Das S., Ramamurthy B., Sangwan V.S. Fungal keratitis following amniotic membrane transplantation. Int Ophthalmol 2009, 29(1):49-51.
9. Marangon F.B., Alfonso E.C., Miller D., Remonda N.M., Muallem M.S., Tseng S.C. Incidence of microbial infection after amniotic membrane transplantation. Cornea 2004, 23(3):264-269.
10. Robinton D.A., Daley G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481(7381):295-305.
11. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451(7175):141-146.
12. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-317.
13. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
14. Li H.Y., Chien Y., Chen Y.J., Chen S.F., Chang Y.L., Chiang C.H., et al. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials 2011, 32(26):5994-6005.
15. Yang K.Y., Shih H.C., How C.K., Chen C.Y., Hsu H.S., Yang C.W., et al. IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest 2011, 140(5):1243-1253.
16. Chen S.J., Chang C.M., Tsai S.K., Chang Y.L., Chou S.J., Huang S.S., et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 2010, 19(11):1757-1767.
17. Zhou L., Wang W., Liu Y., Fernandez de Castro J., Ezashi T., Telugu B.P., et al. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells 2011, 29(6):972-980.
18. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379(9817):713-720.
19. Lin T., Ambasudhan R., Yuan X., Li W., Hilcove S., Abujarour R., et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009, 6(11):805-808.
20. Deb-Rinker P., Ly D., Jezierski A., Sikorska M., Walker P.R. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 2005, 280(8):6257-6260.
21. Huangfu D., Osafune K., Maehr R., Guo W., Eijkelenboom A., Chen S., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008, 26(11):1269-1275.
22. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008, 3(7):e2637.
23. Liu T.Y., Chen S.Y., Lin Y.L., Liu D.M. Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: water-retention ability and drug encapsulation. Langmuir 2006, 22(23):9740-9745.
24. Ling S., Qi C., Li W., Xu J., Kuang W. Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed. Clin Exp Ophthalmol 2009, 37(9):874-883.
25. Liu K.H., Chen B.R., Chen S.Y., Liu D.M. Self-assembly behavior and doxorubicin-loading capacity of acylated carboxymethyl chitosans. J Phys Chem B 2009, 113(35):11800-11807.
26. Svee K., White J., Vaillant P., Jessurun J., Roongta U., Krumwiede M., et al. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 1996, 98(8):1713-1727.
27. Gorin D.R., Cordts P.R., LaMorte W.W., Manzoian J.O. The influence of wound geometry on the measurement of wound healing rates in clinical trials. J Vasc Surg 1996, 23(3):524-528.
28. Armstrong L., Tilgner K., Saretzki G., Atkinson S.P., Stojkovic M., Moreno R., et al. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28(4):661-673.
29. Zhan W., Liu Z., Liu Y., Ke Q., Ding Y., Lu X., et al. Modulation of rabbit corneal epithelial cells fate using embryonic stem cell extract. Mol Vis 2010, 16:1154-1161.
30. Griffith M., Osborne R., Munger R., Xiong X., Doillon C.J., Laycock N.L., et al. Functional human corneal equivalents constructed from cell lines. Science 1999, 286(5447):2169-2172.
31. Gonzalez-Andrades M., de la Cruz Cardona J., Ionescu A.M., Campos A., Del Mar Perez M., Alaminos M. Generation of bioengineered corneas with decellularized xenografts and human keratocytes. Invest Ophthalmol Vis Sci 2011, 52(1):215-222.
32. Guo X., Hutcheon A.E., Melotti S.A., Zieske J.D., Trinkaus-Randall V., Ruberti J.W. Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts. Invest Ophthalmol Vis Sci 2007, 48(9):4050-4060.
33. Du Y., Sundarraj N., Funderburgh M.L., Harvey S.A., Birk D.E., Funderburgh J.L. Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Invest Ophthalmol Vis Sci 2007, 48(11):5038-5045.
34. Crabb R.A., Chau E.P., Evans M.C., Barocas V.H., Hubel A. Biomechanical and microstructural characteristics of a collagen film-based corneal stroma equivalent. Tissue Eng 2006, 12(6):1565-1575.
35. Merrett K., Fagerholm P., McLaughlin C.R., Dravida S., Lagali N., Shinozaki N., et al. Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest Ophthalmol Vis Sci 2008, 49(9):3887-3894.
36. Liu W., Merrett K., Griffith M., Fagerholm P., Dravida S., Heyne B., et al. Recombinant human collagen for tissue engineered corneal substitutes. Biomaterials 2008, 29(9):1147-1158.
37. Nakamura T., Inatomi T., Sotozono C., Ang L.P., Koizumi N., Yokoi N., et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 2006, 113(10):1765-1772.
38. Rama P., Bonini S., Lambiase A., Golisano O., Paterna P., De Luca M., et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 2001, 72(9):1478-1485.
39. Pratoomsoot C., Tanioka H., Hori K., Kawasaki S., Kinoshita S., Tighe P.J., et al. A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair. Biomaterials 2008, 29(3):272-281.
40. Builles N., Janin-Manificat H., Malbouyres M., Justin V., Rovere M.R., Pellegrini G., et al. Use of magnetically oriented orthogonal collagen scaffolds for hemi-corneal reconstruction and regeneration. Biomaterials 2010, 31(32):8313-8322.
41. Maharjan A.S., Pilling D., Gomer R.H. High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. PLoS One 2011, 6(10):e26078.
42. Joddar B., Kitajima T., Ito Y. The effects of covalently immobilized hyaluronic acid substrates on the adhesion, expansion, and differentiation of embryonic stem cells for in vitro tissue engineering. Biomaterials 2011, 32(33):8404-8415.
43. Lu L., Reinach P.S., Kao W.W. Corneal epithelial wound healing. Exp Biol Med (Maywood) 2001, 226(7):653-664.
44. Shortt A.J., Secker G.A., Notara M.D., Limb G.A., Khaw P.T., Tuft S.J., et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 2007, 52(5):483-502.
45. Tseng S.C., Meller D., Anderson D.F., Touhami A., Pires R.T., Gruterich M., et al. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane for treating corneal diseases with total limbal stem cell deficiency. Adv Exp Med Biol 2002, 506(Pt B):1323-1334.
46. Ordonez P., Di Girolamo N. Limbal epithelial stem cells: role of the niche microenvironment. Stem Cells 2012, 30(2):100-107.
47. Hanna C., Bicknell D.S., O'Brien J.E. Cell turnover in the adult human eye. Arch Ophthalmol 1961, 65:695-698.
48. Buck R.C. Measurement of centripetal migration of normal corneal epithelial cells in the mouse. Invest Ophthalmol Vis Sci 1985, 26(9):1296-1299.